Abstract:Fine-tuning of osteoclast differentiation (OD) and bone remodeling is crucial for bone homeostasis. Dissecting the mechanisms regulating osteoclastogenesis is fundamental to understanding the pathogenesis of various bone disorders including osteoporosis and arthritis. Nuclear factor erythroid 2-related factor 1 (NFE2L1, also known as NRF1), which belongs to the CNC-bZIP family of transcription factors, orchestrates a variety of physiological processes and stress responses. While Nfe2l1 gene may be transcribed into multiple alternatively spliced isoforms, the biological function of the different isoforms of NFE2L1 in bone metabolism, osteoclastogenesis in particular, has not been reported. Here we demonstrate that knockout of all isoforms of Nfe2l1 transcripts specifically in the myeloid lineage in mice [Nfe2l1(M)-KO] results in increased activity of osteoclasts, decreased bone mass and worsening of osteoporosis induced by ovariectomy and aging. In comparison, LysM-Cre-mediated Nfe2l1 deletion has no significant effect on the osteoblast and osteocytes. Mechanistic investigations using bone marrow cells and RAW 264.7 cells revealed that deficiency of Nfe2l1 leads to accelerated and elevated OD, which is attributed, at least in part, to enhanced accumulation of ROS in the early stage of OD and expression of nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1α (Nfatc1/α). In addition, NFE2L1 regulates the transcription of multiple antioxidant genes and Nfatc1/α and OD in an isoform-specific manner. While long isoforms of NFE2L1 function as accelerators of induction of Nfatc1/α and antioxidant genes and OD, the short isoform NFE2L1-453 serves as a brake that keeps the long isoforms' accelerator effects in check. These findings provide a novel insight into the regulatory roles of NFE2L1 in osteoclastogenesis and highlight that NFE2L1 is essential in regulating bone remodeling and thus may be a valuable therapeutic target for bone disorders.

NRF2 is essential for iron-overload stimulated osteoclast differentiation through regulation of redox and iron homeostasis

Nrf2 Mitigates RANKL and M-CSF Induced Osteoclast Differentiation via ROS-Dependent Mechanisms

Nrf2 is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells

NRF2, a Superstar of Ferroptosis

CNC-bZIP protein NFE2L1 regulates osteoclast differentiation in antioxidant-dependent and independent manners

NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8

Ferric Ion Could Facilitate Osteoclast Differentiation and Bone Resorption Through the Production of Reactive Oxygen Species

NDR2 is Critical for the Osteoclastogenesis by Regulating ULK1-mediated Mitophagy.

Nrf2 knockout dysregulates iron metabolism and increases the hemolysis through ROS in aging mice

A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis

The Roles of NRF2 in Modulating Cellular Iron Homeostasis

Nrf2 Participates in Progression of Osteoarthritis Through Modulating Redox Balance

NRF2 is a Critical Regulator and Therapeutic Target of Metal Implant Particle-Incurred Bone Damage

Nrf2 protects against cartilage endplate degeneration through inhibiting NCOA4‑mediated ferritinophagy

Fostered Nrf2 expression antagonizes iron overload and glutathione depletion to promote resistance of neuron-like cells to ferroptosis

Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration

Mitochondrial oxidative stress mediated Fe-induced ferroptosis via the NRF2-ARE pathway

The Multifaceted Protective Role of Nuclear Factor Erythroid 2-Related Factor 2 in Osteoarthritis: Regulation of Oxidative Stress and Inflammation

Modulation of osteoblastogenesis by NRF2: NRF2 activation suppresses osteogenic differentiation and enhances mineralization in human bone marrow-derived mesenchymal stromal cells

Toward Improved Human Health: Nrf2 Plays a Critical Role in Regulating Ferroptosis

NRF2, a Transcription Factor for Stress Response and Beyond